SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-23-069012
Filing Date
2023-08-18
Accepted
2023-08-18 16:56:34
Documents
2
Group Members
VIVO ASIA OPPORTUNITY FUND HOLDINGS, L.P.VIVO ASIA OPPORTUNITY, LLCVIVO OPPORTUNITY CO-INVEST, L.P.VIVO OPPORTUNITY, LLCVIVO PANDA FUND, L.P.VIVO PANDA, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea183893-13gvivo_gracell.htm SC 13G 172398
2 JOINT FILING STATEMENT ea183893ex99-1_gracell.htm EX-99.1 12886
  Complete submission text file 0001213900-23-069012.txt   187053
Mailing Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030
Business Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030 00862164031522
Gracell Biotechnologies Inc. (Subject) CIK: 0001826492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91967 | Film No.: 231186509
SIC: 2834 Pharmaceutical Preparations

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity Fund Holdings, L.P. (Filed by) CIK: 0001930214 (see all company filings)

IRS No.: 873802421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G